Industry and geographic information

12 Months Ended

Dec. 31, 2012

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

24. Industry and geographic information:

The Company operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer based technology.

Revenues from GSK represented 46% of total revenues in 2010, 67% in 2011 and 63% in 2012.

Operations outside of France consist principally of the operations of Éclat pharmaceuticals acquired in March 2012 which had sales amounting to $560,000 in 2012.

Revenues by geographic location of customers are as follows:

(in thousands of U.S. dollars)	As of December 31,
	2010		2011		2012
Revenues
United Kingdom & Ireland		16,641		17,619		15,967
USA		3,929		3,694		3,890
France		2,425		1,763		2,930
Europe		14,098		9,524		3,313
Total Revenues		37,094		32,600		26,100

The following is a summary of long-lived assets by geographic location:

(in thousands of U.S. dollars)	As of December 31,
	2011		2012
Long-lived assets:
USA	$	5	$	60,260
France	$	31,600	$	31,966
Total long-lived assets	$	31,605	$	92,226